| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CH5424802 | GDSC1000 | pan-cancer | AAC | 0.15 | 2e-06 |
| mRNA | MPS-1-IN-1 | GDSC1000 | pan-cancer | AAC | 0.13 | 4e-05 |
| mRNA | lapatinib | GDSC1000 | pan-cancer | AAC | 0.18 | 6e-05 |
| mRNA | ML312 | CTRPv2 | pan-cancer | AAC | 0.24 | 0.0004 |
| mRNA | TAE684 | GDSC1000 | pan-cancer | AAC | 0.18 | 0.0004 |
| mRNA | Erlotinib | GDSC1000 | pan-cancer | AAC | 0.16 | 0.0006 |
| mRNA | Crizotinib | GDSC1000 | pan-cancer | AAC | 0.15 | 0.002 |
| mRNA | RO4929097 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.003 |
| mRNA | compound 1B | CTRPv2 | pan-cancer | AAC | 0.11 | 0.004 |
| mRNA | Parthenolide | GDSC1000 | pan-cancer | AAC | 0.14 | 0.004 |